See more : Leonteq AG (LEON.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Science Strategic Acquisition Corp. Alpha (SSAA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Science Strategic Acquisition Corp. Alpha, a leading company in the Shell Companies industry within the Financial Services sector.
- Fuji Pharma Co., Ltd. (4554.T) Income Statement Analysis – Financial Results
- Medley, Inc. (4480.T) Income Statement Analysis – Financial Results
- Vertu Capital Limited (VCBC.L) Income Statement Analysis – Financial Results
- Power Construction Corporation of China, Ltd (601669.SS) Income Statement Analysis – Financial Results
- Electric Royalties Ltd. (ELECF) Income Statement Analysis – Financial Results
Science Strategic Acquisition Corp. Alpha (SSAA)
About Science Strategic Acquisition Corp. Alpha
Science Strategic Acquisition Corp. Alpha does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer (D2C) brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California.
| Metric | 2021 | 2020 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 |
| Other Expenses | -2.95B | 0.00 |
| Operating Expenses | -2.95B | 0.00 |
| Cost & Expenses | -2.95B | 0.00 |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | -3.11B | 0.00 |
| Depreciation & Amortization | 3.11B | 206.30K |
| EBITDA | 158.78M | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -2.95B | 0.00 |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.11B | 0.00 |
| Income Before Tax | 158.78M | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | -3.11B | 0.00 |
| Net Income | 3.26B | 0.00 |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 84.12 | 0.00 |
| EPS Diluted | 84.12 | 0.00 |
| Weighted Avg Shares Out | 38.81M | 38.81M |
| Weighted Avg Shares Out (Dil) | 38.81M | 38.81M |
Source: https://incomestatements.info
Category: Stock Reports